4Bonow RO.New insights into the cardiac natriuretic peptides[J].Circulation,1996,93(11):1946-1950.
5Valli N,Gobinet A,Bordenave L.Review of 10 years of the clinical use of brain natriuretic peptide in cardiology[J].J Lab Clin Med,1999,134(5):437-444.
7Sata N,Tanaka Y, Suzuki S,et al.Effectiveness of angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker on atrial natriuretic peptide[J].Circ J,2003,67(12):1053-1058.
8Bianciotti LG,De Bold AJ.Effect of ET(A) receptor blockade on natriuretic peptide gene experession in DOCA2 salt hypertension[J].Am J Physiol,2000,279(1):93.
9Vasely DL,Chiou S,Douglass MA,et al.Atrial natriuretic peptide negatively and positively modulate circulating endothelin in humans[J].Metabolism,1996,45(3):315.
10Hilal-Dandan R,Ranzirez MT,Villegas S,et al.Endothelin ETA receptor regulates signaling and ANP gene expression via multiple G protein-2-linked pathways[J].Am J Physiol,1997,272(1 pt 2):130-137.
3Choyce A, Avidan MS, Harvey A, et al. The cardiovascular response to insertion of the intubating laryngeal mask airway. Anaesthesia, 2002,57 (4) : 330-333.
4Hein C, Hummer J,Owen H. Evaluation of the SLIPA (streamlined liner of the pharynx airway), a single use supraglottic airway device, in 60 anaesthetized patients undergoing mi nor surgical procedures. Anaesth Intensive Care, 2005,33 (6) 756-761.
5Tanaka A, Isono S, Ishikawa T, et al. Laryngeal resistance before and after minor surgery:endotracheal tube versus Laryngeal Mask Airway. Anesthesiology, 2003,99 (2): 252-258.
